Drugs / Lobeline

Trials 4 · a red edge is where a trial was stopped

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 13 trials
Phase 1 NCT00519259 Feb 2006 → ? methamphetamine dependence National Institute on Drug Abuse (NIDA) Unknown No outcome recorded
Phase 1 NCT00100074 Sep 2004 → Apr 2005 substance-related disorder National Institute on Drug Abuse (NIDA) Unknown No outcome recorded
Phase 1 NCT00439504 methamphetamine dependence National Institute on Drug Abuse (NIDA) Unknown No outcome recorded
Phase 21 trial
Phase 2 NCT00664703 Jul 2008 → Jan 2010 attention deficit-hyperactivity disorder Yaupon Therapeutics Completed No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Lobeline ClinicalTrials.gov intervention name — accepted as the source's own label NCT00519259
3

NCT00100074

NCT00664703

NCT00439504

Known as .alpha.-lobeline ChEMBL registry synonym — accepted as the source's own label CHEMBL122270
Known as Inflatine ChEMBL registry synonym — accepted as the source's own label CHEMBL122270
Known as Lobelina ChEMBL registry synonym — accepted as the source's own label CHEMBL122270
Known as LOBELINE HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL122270
Known as Lobeline sulfate “Drug: Lobeline sulfateNCT00664703
Known as Lobelinum ChEMBL registry synonym — accepted as the source's own label CHEMBL122270
Known as NSC-757421 ChEMBL registry synonym — accepted as the source's own label CHEMBL122270
Modality Small molecule CHEMBL122270
Route Other “Sublingual Lobeline” NCT00519259